Market Place
Sourcing Support
All News #Library
Biotech
Exelixis: Zanzalintinib Combo Boosts OS in Colorectal Cancer
22 Jun 2025 //
BUSINESSWIRE
Fortress Biotech Closes Sale of Checkpoint Therapeutics
30 May 2025 //
GLOBENEWSWIRE
Sun Pharma Completes its Acquisition of Checkpoint Therapeutics
30 May 2025 //
PR NEWSWIRE
Checkpoint Therapeutics Reports 2024 Financial Results & Updates
28 Mar 2025 //
GLOBENEWSWIRE
Sun Pharma to Acquire Checkpoint Therapeutics
10 Mar 2025 //
REUTERS
Checkpoint To Present At H.C. Wainwright Conference
04 Sep 2024 //
GLOBENEWSWIRE
Checkpoint Therapeutics Reports Q2 2024 Results And Corporate Updates
12 Aug 2024 //
GLOBENEWSWIRE
FDA Accepts Checkpoint`s BLA Resubmission For Cosibelimab In CSCC
25 Jul 2024 //
GLOBENEWSWIRE
Checkpoint Therapeutics Resubmits BLA For Cosibelimab
02 Jul 2024 //
GLOBENEWSWIRE
Checkpoint Aligns with FDA for Upcoming Cosibelimab BLA Resubmission
24 Jun 2024 //
GLOBENEWSWIRE
Checkpoint Strengthens Intellectual Property Protection for Cosibelimab
05 Dec 2023 //
GLOBENEWSWIRE
Checkpoint Therapeutics Reports Third Quarter 2023 Financial Results
13 Nov 2023 //
GLOBENEWSWIRE
Checkpoint Therapeutics Reports Second Quarter 2023 Financial Results
14 Aug 2023 //
GLOBENEWSWIRE
Checkpoint Announces Presentation of New Cosibelimab Pharmacokinetic Data
28 Jun 2023 //
GLOBENEWSWIRE
Checkpoint Therapeutics Announces FDA Filing Acceptance of BLA for Cosibelimab
02 Mar 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.